Thornton, Nicole http://orcid.org/0000-0002-8635-0997
Karamatic Crew, Vanja http://orcid.org/0000-0003-1412-9107
Tilley, Louise
Green, Carole A.
Tay, Chwen Ling
Griffiths, Rebecca E. http://orcid.org/0000-0001-7461-0635
Singleton, Belinda K.
Spring, Frances
Walser, Piers
Alattar, Abdul Ghani http://orcid.org/0000-0002-0319-4416
Jones, Benjamin
Laundy, Rosalind
Storry, Jill R. http://orcid.org/0000-0003-2940-2604
Möller, Mattias http://orcid.org/0000-0001-6065-0046
Wall, Lorna http://orcid.org/0000-0001-5536-1207
Charlewood, Richard http://orcid.org/0000-0002-1798-1189
Westhoff, Connie M.
Lomas-Francis, Christine
Yahalom, Vered
Feick, Ute
Seltsam, Axel
Mayer, Beate http://orcid.org/0000-0002-6238-8405
Olsson, Martin L. http://orcid.org/0000-0003-1647-9610
Anstee, David J.
Funding for this research was provided by:
Knut och Alice Wallenbergs Stiftelse (2014.0312)
Swedish governmental ALF grants
DH | National Institute for Health Research (NIHR-BTRU-2015-10032)
Article History
Received: 11 December 2018
Accepted: 29 May 2020
First Online: 16 July 2020
Competing interests
: A patent application (PCT Application No. PCT/GB2019/053102) covering ex vivo erythroid cell culture proliferation enhancement due to lack of or disruption of EMP3 has been filed (N.T., C.A.G., L.T., V.K.C. and D.J.A.). The remaining authors declare no competing interests.